Joseph B. Ciolino, MD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Joseph B. Ciolino, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Joseph B. Ciolino, MD: 4 sponsored US clinical trials, none currently recruiting.
Joseph B. Ciolino, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Other Autoimmune Diseases, with 1 trials.
Upper-quartile sponsor footprint
Joseph B. Ciolino, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients
NCT04584125
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
NCT02863809
Intraductal Meibomian Gland Probing Trial
NCT02256969
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
NCT01582880
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
How the Joseph B. Ciolino, MD early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Other Autoimmune Diseases (1 trial), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Joseph B. Ciolino, MD: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Joseph B. Ciolino, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Joseph B. Ciolino, MD page
4 registered trials is a research-attention snapshot, not an endorsement of Joseph B. Ciolino, MD or any single study.
- None of Joseph B. Ciolino, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Other Autoimmune Diseases is the condition Joseph B. Ciolino, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Other Autoimmune Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Joseph B. Ciolino, MD pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.